ロード中...
Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art
SIMPLE SUMMARY: Over the last ten years, neoadjuvant endocrine therapy (NET) has been increasingly investigated and has gained recognition. NET should not only be used to allow surgery or to improve breast-conserving surgery rates in patients not eligible for NCT, but also as a research tool for the...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7926493/ https://ncbi.nlm.nih.gov/pubmed/33670042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13040902 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|